Purchase Order 75N95025P00461
Award Date
9/29/25
Potential Completion Date
12/26/25
Potential Value
$30K
Federal Agency
National Institute on Drug Abuse
Awardee
Alamar Biosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order award to Alamar Biosciences, Inc. by the National Institute on Aging (NIA), a civilian agency, for $247,000.00. The contract is for providing proteomic analysis services, including the NULISAseq CNS Disease Panel 120 assay, next-generation sequencing, and bioinformatic support for 1,118 plasma samples. The purpose is to identify biomarkers that can be used to classify and stage Alzheimer's disease. This award is not associated with a set-aside and is the...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
This is a $100,000.00 firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to Alamar Biosciences, Inc., a for-profit manufacturer of goods located in Fremont, California. The contract is for the provision of the NULISASEQ MOUSE PANEL, which involves proteomic mouse panel analysis to investigate potential biomarkers. The award does not have a set-aside designation, indicating open market competition. The contract period runs from...
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $183,731.46 firm-fixed-price purchase order contract to Oxford Stemtech LTD for scientific support services related to the generation and multiomics profiling of induced pluripotent stem cell-derived neuronal models. The contract does not have a set-aside designation, and the ultimate completion date is September 10, 2025. This contract award is not associated with a larger acquisition vehicle.</p>
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $24,999.10 firm fixed-price purchase order to Vizioli Omics to complete research and analysis leading to the submission of manuscripts for publication. The contract, which does not have a set-aside designation, has a period of performance through June 24, 2025. This award appears to be for a standalone project and is not associated with a larger contract vehicle.</p>
The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...
<p>The National Institute on Aging, a civilian federal agency, awarded a $17,500.00 Firm Fixed Price Purchase Order to Alamar Biosciences, Inc. to provide laboratory and testing services for the NULISASEQ CNS Disease Panel service. The award has an ultimate completion date of August 11, 2024. The contract does not have a set-aside designation.</p>
The National Institute on Drug Abuse (NIDA) awarded a $106,704.75 firm-fixed-price purchase order to Biocrates Life Sciences AG, an Austrian company, for targeted metabolomics analyses of human brain tissue samples. This contract is not associated with a set-aside designation. Biocrates has extensive experience providing metabolomics assay kits, laboratory services, and targeted metabolite analysis capabilities to support biomedical research across federal agencies such as the NIH, USDA, and...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $2,600.00 firm fixed-price purchase order contract to Neurostatus-Uhb AG, a foreign-owned for-profit organization, for a NeuroStatus e-test license and EDSS training. The contract has an ultimate completion date of December 31, 2025 and was awarded on January 1, 2025. The contract was not set aside for any specific business designation.</p>
Sage Scientific LLC, doing business as Neurophotometerics LTD, has been awarded a $25,000 firm fixed price purchase order contract by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract is for the delivery of a second-generation multi-fiber photometry system to support NIDA's biomedical research efforts. Performance will occur in Baltimore, Maryland over a one year period. No...